1. Home
  2. LBTYA vs IRTC Comparison

LBTYA vs IRTC Comparison

Compare LBTYA & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Global Ltd.

LBTYA

Liberty Global Ltd.

HOLD

Current Price

$11.30

Market Cap

4.0B

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$103.77

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBTYA
IRTC
Founded
2004
2006
Country
Bermuda
United States
Employees
6636
N/A
Industry
Cable & Other Pay Television Services
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.9B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
LBTYA
IRTC
Price
$11.30
$103.77
Analyst Decision
Hold
Strong Buy
Analyst Count
5
13
Target Price
$13.72
$197.92
AVG Volume (30 Days)
1.6M
472.6K
Earning Date
05-01-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.71
EPS
N/A
N/A
Revenue
N/A
$747,138,000.00
Revenue This Year
$15.41
$19.60
Revenue Next Year
$3.03
$15.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.24
52 Week Low
$9.62
$100.85
52 Week High
$13.52
$210.01

Technical Indicators

Market Signals
Indicator
LBTYA
IRTC
Relative Strength Index (RSI) 39.00 37.93
Support Level $10.54 $101.75
Resistance Level $11.53 $121.88
Average True Range (ATR) 0.40 5.30
MACD -0.06 -0.38
Stochastic Oscillator 0.40 15.11

Price Performance

Historical Comparison
LBTYA
IRTC

About LBTYA Liberty Global Ltd.

Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: